Kangyu Bio, a Qianhai Taihe portfolio company, completed its Series C+ funding round, with its valuation exceeding 5 billion RMB.
Kangyu Bio, a Qianhai Taihe portfolio company, completed its Series…
Kangyu Bio, a Qianhai Taihe portfolio company, completed its Series…
A Qianhai Taihe partner attended the Boao Forum for Asia…
Portfolio company Tianji New Energy secured support from a national-level…